Nexien BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	0	1	2	4	5	3
Market Cap Growth	-99.61%	-47.97%	-39.49%	-24.47%	90.11%	-45.30%
Enterprise Value	0	1	3	4	5	3
Last Close Price	0.00	0.02	0.04	0.06	0.09	0.05
PB Ratio	-0.02	-3.30	-9.08	-32.16	-363.58	-413.89
Debt / Equity Ratio	-0.83	-0.86	-1.08	-1.88	-2.39	-1.88
Net Debt / Equity Ratio	-0.81	-0.85	-0.94	-0.89	-1.08	-0.19
Quick Ratio	0.02	0.01	0.12	0.48	0.46	0.37
Current Ratio	0.02	0.01	0.15	0.51	0.65	0.78
Return on Equity (ROE)	-	-	-	-	-	-2058.62%
Return on Assets (ROA)	-655.83%	-411.28%	-210.72%	-469.81%	-4769.09%	-988.36%
Return on Capital Employed (ROCE)	26.30%	43.10%	112.10%	479.60%	13384.90%	41423.20%
Earnings Yield	-2657.65%	-20.08%	-15.81%	-16.56%	-37.14%	-101.41%
Buyback Yield / Dilution	-8.06%	-6.19%	-7.73%	-4.44%	-2.76%	-5.64%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.